1 Dry Powder Inhaler Device Market Overview 1.1 Product Overview and Scope of Dry Powder Inhaler Device 1.2 Dry Powder Inhaler Device Segment by Type 1.2.1 Global Dry Powder Inhaler Device Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Single Dose 1.2.3 Multi Dose 1.3 Dry Powder Inhaler Device Segment by Application 1.3.1 Global Dry Powder Inhaler Device Sales Comparison by Application: (2022-2028) 1.3.2 Asthma 1.3.3 COPD 1.3.4 Others 1.4 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts 1.4.1 Global Dry Powder Inhaler Device Revenue 2017-2028 1.4.2 Global Dry Powder Inhaler Device Sales 2017-2028 1.4.3 Dry Powder Inhaler Device Market Size by Region: 2017 Versus 2021 Versus 2028 2 Dry Powder Inhaler Device Market Competition by Manufacturers 2.1 Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2017-2022) 2.2 Global Dry Powder Inhaler Device Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Dry Powder Inhaler Device Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Dry Powder Inhaler Device Manufacturing Sites, Area Served, Product Type 2.5 Dry Powder Inhaler Device Market Competitive Situation and Trends 2.5.1 Dry Powder Inhaler Device Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Dry Powder Inhaler Device Players Market Share by Revenue 2.5.3 Global Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Dry Powder Inhaler Device Retrospective Market Scenario by Region 3.1 Global Dry Powder Inhaler Device Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Dry Powder Inhaler Device Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Dry Powder Inhaler Device Market Facts & Figures by Country 3.3.1 North America Dry Powder Inhaler Device Sales by Country 3.3.2 North America Dry Powder Inhaler Device Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Dry Powder Inhaler Device Market Facts & Figures by Country 3.4.1 Europe Dry Powder Inhaler Device Sales by Country 3.4.2 Europe Dry Powder Inhaler Device Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Region 3.5.1 Asia Pacific Dry Powder Inhaler Device Sales by Region 3.5.2 Asia Pacific Dry Powder Inhaler Device Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country 3.6.1 Latin America Dry Powder Inhaler Device Sales by Country 3.6.2 Latin America Dry Powder Inhaler Device Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country 3.7.1 Middle East and Africa Dry Powder Inhaler Device Sales by Country 3.7.2 Middle East and Africa Dry Powder Inhaler Device Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Dry Powder Inhaler Device Historic Market Analysis by Type 4.1 Global Dry Powder Inhaler Device Sales Market Share by Type (2017-2022) 4.2 Global Dry Powder Inhaler Device Revenue Market Share by Type (2017-2022) 4.3 Global Dry Powder Inhaler Device Price by Type (2017-2022) 5 Global Dry Powder Inhaler Device Historic Market Analysis by Application 5.1 Global Dry Powder Inhaler Device Sales Market Share by Application (2017-2022) 5.2 Global Dry Powder Inhaler Device Revenue Market Share by Application (2017-2022) 5.3 Global Dry Powder Inhaler Device Price by Application (2017-2022) 6 Key Companies Profiled 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Corporation Information 6.1.2 GlaxoSmithKline Description and Business Overview 6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio 6.1.5 GlaxoSmithKline Recent Developments/Updates 6.2 AstraZeneca 6.2.1 AstraZeneca Corporation Information 6.2.2 AstraZeneca Description and Business Overview 6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio 6.2.5 AstraZeneca Recent Developments/Updates 6.3 Boehringer Ingelheim 6.3.1 Boehringer Ingelheim Corporation Information 6.3.2 Boehringer Ingelheim Description and Business Overview 6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio 6.3.5 Boehringer Ingelheim Recent Developments/Updates 6.4 Chiesi 6.4.1 Chiesi Corporation Information 6.4.2 Chiesi Description and Business Overview 6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio 6.4.5 Chiesi Recent Developments/Updates 6.5 Cipla 6.5.1 Cipla Corporation Information 6.5.2 Cipla Description and Business Overview 6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Cipla Dry Powder Inhaler Device Product Portfolio 6.5.5 Cipla Recent Developments/Updates 6.6 3M 6.6.1 3M Corporation Information 6.6.2 3M Description and Business Overview 6.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.6.4 3M Dry Powder Inhaler Device Product Portfolio 6.6.5 3M Recent Developments/Updates 6.7 Hovione 6.6.1 Hovione Corporation Information 6.6.2 Hovione Description and Business Overview 6.6.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Hovione Dry Powder Inhaler Device Product Portfolio 6.7.5 Hovione Recent Developments/Updates 6.8 Mannkind 6.8.1 Mannkind Corporation Information 6.8.2 Mannkind Description and Business Overview 6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio 6.8.5 Mannkind Recent Developments/Updates 6.9 Mylan 6.9.1 Mylan Corporation Information 6.9.2 Mylan Description and Business Overview 6.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Mylan Dry Powder Inhaler Device Product Portfolio 6.9.5 Mylan Recent Developments/Updates 6.10 Novartis 6.10.1 Novartis Corporation Information 6.10.2 Novartis Description and Business Overview 6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Novartis Dry Powder Inhaler Device Product Portfolio 6.10.5 Novartis Recent Developments/Updates 6.11 Schering/Merck 6.11.1 Schering/Merck Corporation Information 6.11.2 Schering/Merck Dry Powder Inhaler Device Description and Business Overview 6.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio 6.11.5 Schering/Merck Recent Developments/Updates 6.12 Teva 6.12.1 Teva Corporation Information 6.12.2 Teva Dry Powder Inhaler Device Description and Business Overview 6.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Teva Dry Powder Inhaler Device Product Portfolio 6.12.5 Teva Recent Developments/Updates 6.13 Vectura 6.13.1 Vectura Corporation Information 6.13.2 Vectura Dry Powder Inhaler Device Description and Business Overview 6.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Vectura Dry Powder Inhaler Device Product Portfolio 6.13.5 Vectura Recent Developments/Updates 7 Dry Powder Inhaler Device Manufacturing Cost Analysis 7.1 Dry Powder Inhaler Device Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Dry Powder Inhaler Device 7.4 Dry Powder Inhaler Device Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Dry Powder Inhaler Device Distributors List 8.3 Dry Powder Inhaler Device Customers 9 Dry Powder Inhaler Device Market Dynamics 9.1 Dry Powder Inhaler Device Industry Trends 9.2 Dry Powder Inhaler Device Market Drivers 9.3 Dry Powder Inhaler Device Market Challenges 9.4 Dry Powder Inhaler Device Market Restraints 10 Global Market Forecast 10.1 Dry Powder Inhaler Device Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Dry Powder Inhaler Device by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Dry Powder Inhaler Device by Type (2023-2028) 10.2 Dry Powder Inhaler Device Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Dry Powder Inhaler Device by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Dry Powder Inhaler Device by Application (2023-2028) 10.3 Dry Powder Inhaler Device Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Dry Powder Inhaler Device by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Dry Powder Inhaler Device by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Dry Powder Inhaler Device Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Dry Powder Inhaler Device Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Dry Powder Inhaler Device Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Dry Powder Inhaler Device Market Competitive Situation by Manufacturers in 2021 Table 5. Global Dry Powder Inhaler Device Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2017-2022) Table 7. Global Dry Powder Inhaler Device Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Dry Powder Inhaler Device Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Dry Powder Inhaler Device Manufacturing Sites and Area Served Table 11. Manufacturers Dry Powder Inhaler Device Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dry Powder Inhaler Device as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Dry Powder Inhaler Device Sales by Region (2017-2022) & (K Units) Table 16. Global Dry Powder Inhaler Device Sales Market Share by Region (2017-2022) Table 17. Global Dry Powder Inhaler Device Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Dry Powder Inhaler Device Revenue Market Share by Region (2017-2022) Table 19. North America Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units) Table 20. North America Dry Powder Inhaler Device Sales Market Share by Country (2017-2022) Table 21. North America Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022) Table 23. Europe Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units) Table 24. Europe Dry Powder Inhaler Device Sales Market Share by Country (2017-2022) Table 25. Europe Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Dry Powder Inhaler Device Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Dry Powder Inhaler Device Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Region (2017-2022) Table 31. Latin America Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units) Table 32. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2017-2022) Table 33. Latin America Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2017-2022) Table 39. Global Dry Powder Inhaler Device Sales by Type (2017-2022) & (K Units) Table 40. Global Dry Powder Inhaler Device Sales Market Share by Type (2017-2022) Table 41. Global Dry Powder Inhaler Device Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Dry Powder Inhaler Device Revenue Share by Type (2017-2022) Table 43. Global Dry Powder Inhaler Device Price by Type (2017-2022) & (USD/Unit) Table 44. Global Dry Powder Inhaler Device Sales (K Units) by Application (2017-2022) Table 45. Global Dry Powder Inhaler Device Sales Market Share by Application (2017-2022) Table 46. Global Dry Powder Inhaler Device Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Dry Powder Inhaler Device Revenue Share by Application (2017-2022) Table 48. Global Dry Powder Inhaler Device Price by Application (2017-2022) & (USD/Unit) Table 49. GlaxoSmithKline Corporation Information Table 50. GlaxoSmithKline Description and Business Overview Table 51. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. GlaxoSmithKline Dry Powder Inhaler Device Product Table 53. GlaxoSmithKline Recent Developments/Updates Table 54. AstraZeneca Corporation Information Table 55. AstraZeneca Description and Business Overview Table 56. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. AstraZeneca Dry Powder Inhaler Device Product Table 58. AstraZeneca Recent Developments/Updates Table 59. Boehringer Ingelheim Corporation Information Table 60. Boehringer Ingelheim Description and Business Overview Table 61. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Boehringer Ingelheim Dry Powder Inhaler Device Product Table 63. Boehringer Ingelheim Recent Developments/Updates Table 64. Chiesi Corporation Information Table 65. Chiesi Description and Business Overview Table 66. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Chiesi Dry Powder Inhaler Device Product Table 68. Chiesi Recent Developments/Updates Table 69. Cipla Corporation Information Table 70. Cipla Description and Business Overview Table 71. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Cipla Dry Powder Inhaler Device Product Table 73. Cipla Recent Developments/Updates Table 74. 3M Corporation Information Table 75. 3M Description and Business Overview Table 76. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. 3M Dry Powder Inhaler Device Product Table 78. 3M Recent Developments/Updates Table 79. Hovione Corporation Information Table 80. Hovione Description and Business Overview Table 81. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Hovione Dry Powder Inhaler Device Product Table 83. Hovione Recent Developments/Updates Table 84. Mannkind Corporation Information Table 85. Mannkind Description and Business Overview Table 86. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. Mannkind Dry Powder Inhaler Device Product Table 88. Mannkind Recent Developments/Updates Table 89. Mylan Corporation Information Table 90. Mylan Description and Business Overview Table 91. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Mylan Dry Powder Inhaler Device Product Table 93. Mylan Recent Developments/Updates Table 94. Novartis Corporation Information Table 95. Novartis Description and Business Overview Table 96. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Novartis Dry Powder Inhaler Device Product Table 98. Novartis Recent Developments/Updates Table 99. Schering/Merck Corporation Information Table 100. Schering/Merck Description and Business Overview Table 101. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Schering/Merck Dry Powder Inhaler Device Product Table 103. Schering/Merck Recent Developments/Updates Table 104. Teva Corporation Information Table 105. Teva Description and Business Overview Table 106. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Teva Dry Powder Inhaler Device Product Table 108. Teva Recent Developments/Updates Table 109. Vectura Corporation Information Table 110. Vectura Description and Business Overview Table 111. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Vectura Dry Powder Inhaler Device Product Table 113. Vectura Recent Developments/Updates Table 114. Production Base and Market Concentration Rate of Raw Material Table 115. Key Suppliers of Raw Materials Table 116. Dry Powder Inhaler Device Distributors List Table 117. Dry Powder Inhaler Device Customers List Table 118. Dry Powder Inhaler Device Market Trends Table 119. Dry Powder Inhaler Device Market Drivers Table 120. Dry Powder Inhaler Device Market Challenges Table 121. Dry Powder Inhaler Device Market Restraints Table 122. Global Dry Powder Inhaler Device Sales Forecast by Type (2023-2028) & (K Units) Table 123. Global Dry Powder Inhaler Device Sales Market Share Forecast by Type (2023-2028) Table 124. Global Dry Powder Inhaler Device Revenue Forecast by Type (2023-2028) & (US$ Million) Table 125. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Type (2023-2028) Table 126. Global Dry Powder Inhaler Device Sales Forecast by Application (2023-2028) & (K Units) Table 127. Global Dry Powder Inhaler Device Sales Market Share Forecast by Application (2023-2028) Table 128. Global Dry Powder Inhaler Device Revenue Forecast by Application (2023-2028) & (US$ Million) Table 129. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Application (2023-2028) Table 130. Global Dry Powder Inhaler Device Sales Forecast by Region (2023-2028) & (K Units) Table 131. Global Dry Powder Inhaler Device Sales Market Share Forecast by Region (2023-2028) Table 132. Global Dry Powder Inhaler Device Revenue Forecast by Region (2023-2028) & (US$ Million) Table 133. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Region (2023-2028) Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Dry Powder Inhaler Device Figure 2. Global Dry Powder Inhaler Device Market Share by Type in 2021 & 2028 Figure 3. Single Dose Product Picture Figure 4. Multi Dose Product Picture Figure 5. Global Dry Powder Inhaler Device Market Share by Application in 2021 & 2028 Figure 6. Asthma Figure 7. COPD Figure 8. Others Figure 9. Global Dry Powder Inhaler Device Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Dry Powder Inhaler Device Market Size (2017-2028) & (US$ Million) Figure 11. Global Dry Powder Inhaler Device Sales (2017-2028) & (K Units) Figure 12. Dry Powder Inhaler Device Sales Share by Manufacturers in 2021 Figure 13. Global Dry Powder Inhaler Device Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Dry Powder Inhaler Device Players: Market Share by Revenue in 2021 Figure 15. Dry Powder Inhaler Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Dry Powder Inhaler Device Sales Market Share by Region (2017-2022) Figure 17. Global Dry Powder Inhaler Device Sales Market Share by Region in 2021 Figure 18. Global Dry Powder Inhaler Device Revenue Market Share by Region (2017-2022) Figure 19. Global Dry Powder Inhaler Device Revenue Market Share by Region in 2021 Figure 20. U.S. Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Taiwan Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Philippines Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Vietnam Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Mexico Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Brazil Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Argentina Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Turkey Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Saudi Arabia Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. U.A.E Dry Powder Inhaler Device Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Sales Market Share of Dry Powder Inhaler Device by Type (2017-2022) Figure 45. Manufacturing Cost Structure of Dry Powder Inhaler Device Figure 46. Manufacturing Process Analysis of Dry Powder Inhaler Device Figure 47. Dry Powder Inhaler Device Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

GlaxoSmithKline AstraZeneca Boehringer Ingelheim Chiesi Cipla 3M Hovione Mannkind Mylan Novartis Schering/Merck Teva Vectura